ClinicalTrials.Veeva

Menu

Barberry and Cardiometabolic Risk Factors in Individuals With Hypertriglyceridemia

S

Shahid Beheshti University

Status

Completed

Conditions

Hyperlipidemias
Hypertriglyceridemia

Treatments

Other: Dried barberry
Other: Low-calorie diet

Study type

Interventional

Funder types

Other

Identifiers

NCT06483932
43008122

Details and patient eligibility

About

Barberry is a well-documented medicinal plant that is utilized as a feed additive in a variety of food cultures. Barberry is a rich source of antioxidants, minerals, phenolic compounds, and flavonoids. Based on the results of animal and human studies, barberry may have therapeutic and medicinal properties, including the ability to improve blood lipid profile. The present study will investigate the effect of seedless barberry consumption on cardiometabolic factors in overweight or obese individuals with mild to moderate hypertriglyceridemia.

Full description

This study is an open-label, randomized, controlled clinical trial and will recruit those who are willing to participate and meet the inclusion criteria. Inclusion criteria are fasting serum triglycerides 150-499 mg/dL, body mass index 25-40 kg/m2, age range 18-75 years. Exclusion criteria are regular use of drugs of the fibrate family, regular use of fish oil supplements or omega-3 supplements or flax seed or chia seed, treatment with glucocorticoids, end-stage renal disease. Subjects who agree to participate in the study will be randomly assigned to one of two study groups. All patients in both groups will be prescribed a low-calorie diet. In the first group, 10 grams of powdered seedless barberry will be consumed daily in addition to the low-calorie diet. The second group (control group) will continue with the low calorie diet. The study will last 8 weeks. Patients are asked to refrain from using over-the-counter herbal medicines and dietary supplements during the study. A baseline fasting blood sample, blood pressure measurements, and anthropometric indices will be obtained. Subsequent assessments will be made at four-week and eight-week intervals.

Enrollment

56 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Fasting serum triglycerides 150-499 mg/dL,
  • Body mass index 25-40 kg/m2
  • Age range 18-75 years

Exclusion criteria

  • Regular use of drugs of the fibrate family, fish oil supplements or omega-3 supplements
  • Regular consumption of flax seed or chia seed
  • Treatment with glucocorticoids
  • End-stage renal disease

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

56 participants in 2 patient groups

Control
Active Comparator group
Description:
A diet with a reduced calorie intake
Treatment:
Other: Low-calorie diet
Barberry
Experimental group
Description:
A diet with a reduced calorie intake, coupled with the consumption of barberry
Treatment:
Other: Low-calorie diet
Other: Dried barberry

Trial contacts and locations

1

Loading...

Central trial contact

Zahra Kashani, Msc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems